Table 2 Minimum Important Difference (MID's) and Effect Sizes (SRM's)
Study/patient group | N | MID – Mean change in SF-6D (95% CI)* | Standard Deviation | Effect Size (SRM) (95% CI)* | 0.5 of a Standard Deviation |
|---|---|---|---|---|---|
Older adults 1st follow-up | 1362 | 0.039 (0.034 to 0.044) | 0.099 | 0.39 (0.35 to 0.45) | 0.050 |
Older adults 2nd follow-up | 948 | 0.026 (0.021 to 0.033) | 0.096 | 0.27 (0.22 to 0.34) | 0.048 |
IBS patients | 56 | 0.023 (-0.001 to 0.050) | 0.096 | 0.24 (-0.03 to 0.52) | 0.048 |
IBS control patients | 27 | 0.025 (-0.013 to 0.071) | 0.113 | 0.22 (-0.15 to 0.62) | 0.057 |
Leg ulcer patients | 45 | 0.032 (-0.001 to 0.071) | 0.131 | 0.24 (-0.06 to 0.53) | 0.066 |
OA Knee patients | 59 | 0.032 (0.015 to 0.049) | 0.066 | 0.49 (0.22 to 0.73) | 0.033 |
Limb reconstruction patients | 29 | 0.048 (0.007 to 0.091) | 0.120 | 0.40 (-0.02 to 0.79) | 0.060 |
Early (RA) patients | 99 | 0.039 (0.017 to 0.061) | 0.112 | 0.33 (0.14 to 0.58) | 0.056 |
COPD Patients | 29 | 0.010 (-0.019 to 0.043) | 0.087 | 0.11 (-0.28 to 0.47) | 0.044 |